StimZ By FINAFLEX Overview & Drug Interactions

Check For Interactions With StimZ

Supplement: StimZ by FINAFLEX

StimZ Label Images

This product contains

Below is a list of the 'active' ingredients listed on the supplement label for this product.

For a list of 'other ingredients', such as fillers, please see the 'Label Information' section on this page.

Drugs that interact with StimZ by FINAFLEX

Below is a list of drug interactions for each ingredient in this supplement product. Please note that a supplement product may contain more than one ingredient that has interactions.

Label Information

Supplement Facts:

Daily Value (DV) Target Group(s): Adults and children 4 or more years of age
Minimum serving Sizes:
1 Tablet(s)
Maximum serving Sizes:
1 Tablet(s)
Servings per container 45
UPC/BARCODE 689466777178

Ingredient Amount per Serving Group % DV, Adults & children 4+ years
StimZ Energy Matrix
278 mg
Blend (Combination) --
1,3,7-Trimethylxanthine
0 NP
Caffeine
IRISINXD
0 NP
Proprietary Blend (Combination)
Theobroma cacao seed extract
0 NP
cocoa
Rauwolfia vomitoria
0 NP
African Snakeroot

Other Ingredients:
Dicalcium Phosphate Dihydrate
Microcrystalline Cellulose
Stearic Acid
Croscarmellose Sodium
Silica
Magnesium Stearate


Label Statments:


FDA Statement of Identity
- Dietary Supplement - 45 tablets
- Dietary Supplement
Precautions
- Warning: Keep out of reach of children.
- Do not use if pregnant or nursing.
- Consult your physician prior to use if you have or are at risk for prostate disease, heart disease, or any other general medical condition.
- Consult your doctor prior to use if you are taking any other medications.
- All persons are advised to consult with their doctor or other medical authority before use of this or any other dietary supplement. Discontinue use immediately if you experience any adverse symptoms or reactions while taking this product. Warning: Avoid excessive caffeine and intake of other stimulants while using this product.
- Discuss possible interactions and contradictions of this dietary supplement with other medicines currently prescribed by your doctor.
- Do not use this product in extreme heat conditions. Discontinue use 2 weeks prior to surgery. Do not combine this product with alcohol. Do not use if your health status is unknown. Do not use this product 5 hours prior to bedtime. Caution: Athletes or other persons who are subject to testing for performance enhancing drugs may test positive when using dietary supplements. All persons are advised to contact their drug testing organization prior to use of this or any other dietary supplement.
- May not be suitable for persons under the age of 18 years old.
- Do not exceed recommended dosage. Do not use for more than 45 days consecutively.
FDA Disclaimer Statement
- These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
General Statements
- Ultimate energy Stimulant tablets Unparalleled clean energy Complete weight management
Brand IP Statement(s)
- IRISINXD is a registered trademark of FinaFlex, protected by Patent Pending, Serial No. US 14/053,172.
- Redefine yourself.
Suggested/Recommended/Usage/Directions
- Suggested use: As a dietary supplement take 1 StimZ tablet 1 to 2 times daily. Do not exceed recommended dosage. Do not use for more than 45 days consecutively.

Brand Information

See all products by this brand

Manufactured exclusively for:
Name FinaFlex
Street Address 1190 Tidwell Road, Ste 304
City Alpharetta
State GA
Country USA
ZipCode 30004
Web Address www.FinaFlex.com

Return to the main supplement interaction checker page

Parts of this content are provided by the Therapeutic Research Center, LLC and the Dietary Supplement Label Database.

DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.

© 2021 Therapeutic Research Center, LLC

Drug descriptions are provided by MedlinePlus.